The fight is on in the courts over whether Lipitor, a hugely popular drug in the in the US for cholesterol control, actually raises the risk of type 2 diabetes. There is multidistrict litigation in the federal courts surrounding the claims. We are keeping a close eye on the situation as it unfolds.
Pfizer, the maker of the drug, won a boon in the court regarding expert testimony that could put plaintiff’s claims at risk. The plaintiffs had four general causation experts expected to testify about how Lipitor causes type 2 diabetes. The judge has limited the number they could bring forward to just one.
Not only that, but the causation expert could only talk about the effects of Lipitor when taken at the highest level of dosage, 80 milligrams. 10, 20, and 40 mg doses are much more common.
These restrictions could jeopardize the claims that the plaintiffs are putting forward. We shall see how the case unfolds. Millions of people take Lipitor. If it is shown to raise type 2 diabetes risks in the courts, it will be a major blow to Pfizer.
If you take Lipitor or another statin drug and you’ve developed type 2 diabetes, you may be eligible for compensation. Join the fight by contacting John Foy & associates for a free consultation.